Webb D J, Hussaini I M, Weaver A M, Atkins T L, Chu C T, Pizzo S V, Owens G K, Gonias S L
Department of Pathology, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
Eur J Biochem. 1995 Dec 15;234(3):714-22. doi: 10.1111/j.1432-1033.1995.714_a.x.
Vascular smooth muscle cell (vSMC) proliferation is important in atherosclerosis. We previously demonstrated that methylamine-activated alpha 2-macroglobulin (alpha 2M) and transforming growth factor beta 1 (TGF-beta 1) cause a synergistic proliferative response in quiescent rat aortic vSMCs [Stouffer, G. A., La-Marre, J., Gonias, S. L. & Owens, G. K. (1993) J. Biol. Chem. 268, 18,340-18,344]. The first goal of this study was to determine whether the synergy is due to the ability of alpha 2M-methylamine (alpha 2M-MeNH2) to bind TGF-beta 1 and target the growth factor to vSMCs that express the alpha 2M receptor. Receptor-recognized alpha 2M derivatives without TGF-beta 1-binding activity, including ternary alpha 2M-trypsin, an 18-kDa proteolytic fragment of the alpha 2M subunit, and the corresponding recombinant receptor-binding fragment (rRBF) increased vSMC [3H]thymidine incorporation and cell number in a manner similar to alpha 2M-MeNH2. In combination with TGF-beta 1, each alpha 2M derivative caused a synergistic vSMC proliferative response. vSMCs responded comparably when treated with alpha 2M-MeNH2 and TGF-beta 1 simultaneously or in sequence. Furthermore, alpha 2M-MeNH2-TGF-beta 1 complexes increased [3H]thymidine incorporation no more than alpha 2M-MeNH2 alone. These results indicate that TGF-beta 1 binding to alpha 2M is not responsible for the synergistic mitogenic activity. Additional studies were undertaken to determine whether activated alpha 2M independently induces a signal-transduction response in vSMCs. alpha 2M-MeNH2 and rRBF caused a rapid, transient increase in vSMC inositol 1,4,5-trisphosphate. This response was pertussis-toxin insensitive. Receptor-associated protein (RAP; 170 nmol/L) inhibited 91-95% of the specific binding of 125I-alpha 2M-MeNH2 and 125I-rRBF to vSMC; however, RAP did not affect the inositol 1,4,5-trisphosphate response or the mitogenic response. These studies suggest that vSMCs express a receptor, other than low-density-lipoprotein-receptor-related protein, that transduces a signal in response to activated alpha 2M. This receptor may mediate the mitogenic activity of alpha 2M in vSMC culture.
血管平滑肌细胞(vSMC)增殖在动脉粥样硬化中起重要作用。我们先前证明,甲胺激活的α2巨球蛋白(α2M)和转化生长因子β1(TGF-β1)在静止的大鼠主动脉vSMC中引起协同增殖反应[斯托弗,G. A.,拉-马雷,J.,戈尼亚斯,S. L. & 欧文斯,G. K.(1993年)《生物化学杂志》268,18340 - 18344]。本研究的首要目标是确定这种协同作用是否归因于α2M - 甲胺(α2M - MeNH2)结合TGF-β1并将生长因子靶向表达α2M受体的vSMC的能力。没有TGF-β1结合活性的受体识别的α2M衍生物,包括三元α2M - 胰蛋白酶、α2M亚基的18 kDa蛋白水解片段以及相应的重组受体结合片段(rRBF),以类似于α2M - MeNH2的方式增加vSMC的[3H]胸苷掺入和细胞数量。与TGF-β1联合使用时,每种α2M衍生物都引起协同的vSMC增殖反应。vSMC在同时或依次用α2M - MeNH2和TGF-β1处理时反应相当。此外,α2M - MeNH2 - TGF-β1复合物增加的[3H]胸苷掺入不超过单独的α2M - MeNH2。这些结果表明,TGF-β1与α2M的结合并非协同促有丝分裂活性的原因。还进行了其他研究以确定激活的α2M是否独立地在vSMC中诱导信号转导反应。α2M - MeNH2和rRBF引起vSMC肌醇1,4,5 - 三磷酸的快速、短暂增加。这种反应对百日咳毒素不敏感。受体相关蛋白(RAP;170 nmol/L)抑制125I - α2M - MeNH2和125I - rRBF与vSMC特异性结合的91 - 95%;然而,RAP不影响肌醇1,4,5 - 三磷酸反应或促有丝分裂反应。这些研究表明,vSMC表达一种除低密度脂蛋白受体相关蛋白之外的受体,该受体在响应激活的α2M时转导信号。该受体可能介导α2M在vSMC培养中的促有丝分裂活性。